Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)
Phase: N/A
Priority: Normal
Start: 01/24/20
End: 05/30/23
Due: 05/30/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial) | NCT04125732 | XyloCor Therapeutics, Inc. | user2@example.com | None | 2020-01-24 | 2023-05-30 | 2024-05-30 | - | - | 2025-07-14 |